KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Retained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Vir Biotechnology (VIR) Accumulated Depreciation (2018 - 2023)

Historic Accumulated Depreciation for Vir Biotechnology (VIR) over the last 6 years, with Q1 2023 value amounting to $26.2 million.

  • Vir Biotechnology's Accumulated Depreciation rose 6505.69% to $26.2 million in Q1 2023 from the same period last year, while for Mar 2023 it was $26.2 million, marking a year-over-year increase of 6505.69%. This contributed to the annual value of $20.7 million for FY2022, which is 4313.41% up from last year.
  • As of Q1 2023, Vir Biotechnology's Accumulated Depreciation stood at $26.2 million, which was up 6505.69% from $20.7 million recorded in Q4 2022.
  • In the past 5 years, Vir Biotechnology's Accumulated Depreciation ranged from a high of $26.2 million in Q1 2023 and a low of $4.2 million during Q3 2019
  • In the last 5 years, Vir Biotechnology's Accumulated Depreciation had a median value of $11.8 million in 2021 and averaged $12.5 million.
  • In the last 5 years, Vir Biotechnology's Accumulated Depreciation skyrocketed by 18158.51% in 2019 and then soared by 4313.41% in 2022.
  • Quarter analysis of 5 years shows Vir Biotechnology's Accumulated Depreciation stood at $4.8 million in 2019, then soared by 91.06% to $9.2 million in 2020, then soared by 56.98% to $14.5 million in 2021, then surged by 43.13% to $20.7 million in 2022, then increased by 26.54% to $26.2 million in 2023.
  • Its Accumulated Depreciation was $26.2 million in Q1 2023, compared to $20.7 million in Q4 2022 and $18.9 million in Q3 2022.